ABOUT US

We are delighted to invite you to the prestigious 4th Global Summit on Pharmaceutical Research, scheduled to take place on May 09-10, 2024 in Barcelona, Spain. This highly anticipated conference will be a gathering of eminent scientists, researchers, academicians, and industry professionals from around the world, dedicated to advancing the field of pharmaceutical research and innovation. Hosted in an inspiring location, the summit promises an intellectually stimulating environment, fostering collaborations and discussions on the latest breakthroughs and advancements in drug discovery, development, and therapeutics. With an extensive program featuring keynote presentations, expert panels, interactive workshops, and poster sessions, attendees will have ample opportunities to share their knowledge, insights, and research findings. The conference will cover a wide range of topics, including precision medicine, biopharmaceuticals, nanotechnology in drug delivery, pharmacovigilance, and more. Moreover, emerging trends in pharmaceutical research, such as personalized therapies and digital health applications, will be explored in-depth. This event offers a unique platform to network with leading minds in the pharmaceutical industry, exchange ideas, and foster collaborations. Register now to secure your spot at the 4th Global Summit on Pharmaceutical Research, where groundbreaking discoveries and transformative solutions await. Join us for an unforgettable experience at the forefront of pharmaceutical research on May 09-10, 2024.

SESSIONS & TRACKS

Session on Advances in Drug Discovery and Development

Advances in Drug Discovery and Development represent a pivotal domain in modern pharmaceutical research, continuously shaping the landscape of healthcare. This interdisciplinary field explores novel strategies, technologies, and methodologies aimed at discovering and developing safe and effective therapeutic agents to combat various diseases. The subject highlights cutting-edge research in target identification, high-throughput screening, rational drug design, and structure-based drug optimization. Furthermore, it delves into the integration of artificial intelligence, machine learning, and big data analytics to expedite drug discovery processes. By fostering collaboration between researchers, academics, and industry experts, this subject facilitates knowledge exchange and the translation of scientific findings into practical applications. It serves as a platform to discuss challenges, explore innovative approaches, and address unmet medical needs, ultimately advancing the development of new drugs and improving patient outcomes. Advances in Drug Discovery and Development is a vital theme at pharmaceutical conferences, igniting discussions that lead to transformative breakthroughs and contribute to the betterment of global healthcare.

Session  Precision Medicine and Personalized Therapies

Precision Medicine and Personalized Therapies epitomize a paradigm shift in healthcare, tailoring medical treatments to individual patients based on their unique genetic, environmental, and lifestyle factors. This groundbreaking field explores the integration of advanced technologies, such as Genomics, Proteomics, and Bioinformatics, to identify precise molecular signatures and therapeutic targets for personalized interventions. The subject delves into the latest advancements in precision medicine, including companion diagnostics, biomarker discovery, and targeted therapies. By stratifying patients into subgroups based on their molecular profiles, healthcare providers can optimize treatment regimens, enhance therapeutic efficacy, and minimize adverse effects. The conference on Precision Medicine and Personalized Therapies brings together leading scientists, clinicians, and researchers to exchange knowledge, discuss challenges, and explore emerging trends. Through collaborative efforts and interdisciplinary discussions, this subject aims to accelerate the implementation of personalized medicine, revolutionizing patient care and improving health outcomes for diverse populations.

Session on  Biopharmaceuticals and Biotherapeutics

Biopharmaceuticals and Biotherapeutics are at the forefront of modern medicine, offering innovative and targeted therapeutic solutions. This subject delves into the realm of biological products derived from living organisms, including monoclonal antibodies, recombinant proteins, vaccines, and cell-based therapies. The subject explores the latest advancements in biopharmaceutical research, from upstream bioprocessing and cell culture optimization to downstream purification and formulation. Moreover, it delves into the critical aspects of biopharmaceutical development, such as quality control, stability, and regulatory considerations. The conference on Biopharmaceuticals and Biotherapeutics serves as a platform for leading scientists, researchers, and industry professionals to exchange insights, share novel discoveries, and foster collaborations. This interdisciplinary gathering facilitates the translation of cutting-edge research into transformative treatments, addressing unmet medical needs and enhancing patient care worldwide. With the potential to revolutionize disease management and personalized medicine, Biopharmaceuticals and Bio therapeutics represent a dynamic subject that continues to push the boundaries of therapeutic interventions in the ever-evolving landscape of pharmaceutical research.

Session on Nanotechnology in Pharmaceutical Research

Nanotechnology in Pharmaceutical Research represents a ground-breaking and transformative field that integrates Nano scale materials and devices into drug discovery, development, and delivery. This subject explores the application of nanotechnology to address critical challenges in pharmaceutical research, offering innovative solutions for improved therapeutic outcomes. The subject delves into various Nano systems, such as liposomes, nanoparticles, and micelles, designed to enhance drug solubility, stability, and targeted delivery. Moreover, it encompasses the use of nanotechnology in diagnostics, imaging, and personalized medicine, enabling precise disease detection and tailored treatment regimens. The conference on Nanotechnology in Pharmaceutical Research brings together leading experts, researchers, and industry professionals to exchange knowledge, discuss emerging trends, and explore future directions. By fostering collaborations and interdisciplinary discussions, this subject paves the way for the development of nanotechnology-based pharmaceuticals with enhanced efficacy, reduced side effects, and improved patient compliance. As nanotechnology continues to advance, its integration into pharmaceutical research holds immense promise, ushering in a new era of therapeutics and propelling the pharmaceutical industry towards more effective and patient-centric healthcare solutions.

Session on Pharmacovigilance and Drug Safety

Pharmacovigilance and Drug Safety are integral pillars of the pharmaceutical industry, dedicated to monitoring and assessing the safety profile of drugs throughout their lifecycle. This subject explores the critical role of pharmacovigilance in identifying, evaluating, and preventing adverse drug reactions (ADRs) to ensure patient safety. The subject encompasses the collection and analysis of data from healthcare professionals, patients, and regulatory agencies to detect and manage potential risks associated with pharmaceutical products. It also delves into the implementation of risk management strategies and the continuous evaluation of drug safety profiles. The conference on Pharmacovigilance and Drug Safety convenes experts, pharmacists, and regulators to discuss best practices, challenges, and technological advancements in pharmacovigilance. By fostering collaborations and knowledge exchange, this subject aims to strengthen drug safety surveillance, expedite regulatory decision-making, and promote public confidence in pharmaceutical products. As the pharmaceutical industry evolves, pharmacovigilance remains an indispensable process in ensuring that drugs are safe, effective, and beneficial to patients, reflecting the industry's commitment to patient welfare and public health.

Session on Drug Repurposing and Rejuvenation

Drug Repurposing and Rejuvenation is a promising and cost-effective approach in pharmaceutical research that involves finding new therapeutic applications for existing drugs or identifying novel uses for established compounds. This subject explores the exploration of drugs beyond their original indications, uncovering their potential in treating different diseases or medical conditions. The subject delves into the strategic repurposing of drugs for rare diseases, cancer, infectious diseases, and other unmet medical needs. By capitalizing on existing safety and pharmacokinetic data, drug repurposing accelerates the drug development process, shortens the time to market, and reduces the financial burden. The conference on Drug Repurposing and Rejuvenation brings together experts, researchers, and industry professionals to discuss success stories, challenges, and emerging trends in this dynamic field. By fostering collaborations and knowledge exchange, this subject aims to drive innovation, inspire new research directions, and optimize therapeutic outcomes through the repurposing of existing drugs, offering a valuable avenue to expand treatment options and improve patient care.

Session on Pharmaceutical Formulation and Delivery Systems

Pharmaceutical Formulation and Delivery Systems represent a vital area in pharmaceutical research, focused on developing optimized drug formulations and innovative delivery methods to enhance therapeutic efficacy and patient compliance. This subject delves into the design, development, and optimization of drug delivery systems, including oral, parenteral, transdermal, and inhalation routes. The subject explores cutting-edge research in nanotechnology, liposomal formulations, controlled-release systems, and personalized medicine approaches, aiming to improve drug bioavailability and stability while reducing side effects. The conference on Pharmaceutical Formulation and Delivery Systems brings together leading researchers, formulation scientists, and industry experts to exchange knowledge, share discoveries, and discuss emerging trends. By fostering interdisciplinary collaborations and discussions, this subject aims to propel drug delivery innovation, addressing challenges in drug formulation and ensuring safe and efficient therapeutic delivery, ultimately advancing the field of pharmaceutical research and improving patient outcomes.

Session on Drug Resistance and Antimicrobial Stewardship

Drug Resistance and Antimicrobial Stewardship are critical subjects that address the global challenge of antimicrobial resistance, a growing concern in public health. This subject focuses on understanding and combating the rise of drugresistant pathogens through prudent and responsible use of antimicrobial agents. The subject delves into the mechanisms of drug resistance, the development of novel antimicrobial therapies, and strategies for preserving the effectiveness of existing antibiotics. Antimicrobial stewardship initiatives play a pivotal role in promoting appropriate antimicrobial use, optimizing patient outcomes, and curbing the spread of resistance. The conference on Drug Resistance and Antimicrobial Stewardship brings together leading experts, microbiologists, infectious disease specialists, and policymakers to share knowledge, discuss best practices, and explore innovative interventions. By fostering collaboration and knowledge exchange, this subject aims to develop comprehensive antimicrobial stewardship programs and strategies to safeguard the effectiveness of antimicrobial agents, preserving these essential tools for combating infectious diseases and ensuring patient safety.

Session on Pharmaceutical Analytics and Big Data in Research

Pharmaceutical Analytics and Big Data in Research represent a transformative field that leverages advanced data analytics and big data technologies to revolutionize pharmaceutical research and development. This subject explores the integration of data-driven approaches, artificial intelligence, and machine learning to extract meaningful insights from vast and complex datasets. The subject delves into the application of big data in drug discovery, clinical trials, and real-world evidence studies, enabling more efficient decision-making and accelerating the drug development process. Pharmaceutical analytics utilizes predictive modeling, data visualization, and network analysis to identify potential drug targets, optimize trial designs, and personalize treatment regimens. The conference on Pharmaceutical Analytics and Big Data in Research convenes experts, data scientists, and researchers to share innovative methodologies and successful case studies. By fostering collaboration and knowledge exchange, this subject aims to harness the power of big data in pharmaceutical research, facilitating transformative discoveries and advancing the development of novel therapeutics for improved patient care.

Session on Regulatory Science and Compliance in Pharmaceuticals

Regulatory Science and Compliance in Pharmaceuticals is a critical subject that ensures the safety, efficacy, and quality of pharmaceutical products throughout their lifecycle. This interdisciplinary field encompasses the development and implementation of robust regulatory strategies, adherence to international guidelines, and compliance with local regulations. The subject explores the role of regulatory agencies in drug approval and post-marketing surveillance, as well as the importance of Good Manufacturing Practices (GMP) in ensuring product quality and consistency. It also delves into the challenges and advancements in regulatory science, including the evaluation of novel therapies, orphan drug designations, and expedited pathways for rare diseases. The conference on Regulatory Science and Compliance in Pharmaceuticals brings together experts, regulators, and industry professionals to exchange knowledge, discuss evolving regulations, and explore best practices. By fostering collaboration and knowledge exchange, this subject aims to promote global harmonization, expedite drug approvals, and safeguard public health through effective regulatory oversight in the pharmaceutical industry.

Session on Pharmaceutical Manufacturing and Quality Control

Pharmaceutical Manufacturing and Quality Control form the backbone of the pharmaceutical industry, ensuring that drugs are produced to the highest standards of quality, safety, and efficacy. This subject delves into the various aspects of drug manufacturing, including formulation development, process optimization, and technology advancements. The subject explores the implementation of Good Manufacturing Practices (GMP) to maintain consistency and reliability in pharmaceutical production. Quality control measures encompass rigorous testing and analysis of raw materials, intermediates, and finished products to meet stringent regulatory requirements. The conference on Pharmaceutical Manufacturing and Quality Control brings together experts, researchers, and industry professionals to share best practices, discuss innovative manufacturing technologies, and address challenges in quality control. By fostering collaboration and knowledge exchange, this subject aims to drive continuous improvement in pharmaceutical manufacturing processes, ensuring that patients receive safe and effective medications while maintaining high-quality standards across the pharmaceutical supply chain.

Session on Pharmacokinetics and Pharmacodynamics

Pharmacokinetics and Pharmacodynamics are fundamental subjects in pharmaceutical research, investigating the interactions between drugs and the human body. Pharmacokinetics focuses on drug absorption, distribution, metabolism, and excretion (ADME), exploring how the body processes medications over time. Pharmacodynamics, on the other hand, studies the drug's effects on the body, including the drug's mechanism of action, therapeutic effects, and adverse reactions. This subject delves into the application of pharmacokinetics and pharmacodynamics in drug development, dosing regimen optimization, and therapeutic monitoring. It explores how drug properties and patient characteristics influence drug responses, guiding individualized treatment strategies. The conference on Pharmacokinetics and Pharmacodynamics brings together experts, pharmacologists, and clinicians to share research findings and discuss advancements in modeling and simulation approaches. By fostering knowledge exchange, this subject aims to optimize drug therapy, minimize toxicity, and enhance treatment outcomes, ultimately advancing the field of pharmaceutical research and patient care.

Session on Immunotherapy and Immuno-Oncology

Immunotherapy and Immuno-Oncology are revolutionary subjects at the forefront of cancer treatment, harnessing the power of the immune system to combat cancer cells. This subject explores innovative therapeutic approaches that stimulate or modulate the immune response to target and eliminate cancer cells selectively. The subject delves into various immunotherapies, including immune checkpoint inhibitors, CAR-T cell therapy, cancer vaccines, and adoptive T cell therapy. It explores the mechanisms of action and clinical applications of these therapies, both as Monotherapies and in combination with other treatments. The conference on Immunotherapy and Immuno-Oncology brings together leading scientists, oncologists, and immunologists to share cutting-edge research and clinical insights. By fostering interdisciplinary discussions and knowledge exchange, this subject aims to accelerate the development and implementation of immunotherapies, paving the way for transformative treatments and improved outcomes for cancer patients.

Session on Gene Therapy and Cell-Based Therapies

Gene Therapy and Cell-Based Therapies are innovative subjects that hold tremendous potential in revolutionizing medical treatments. This interdisciplinary field explores the use of genes and cells to treat genetic disorders, inherited diseases, and complex conditions with limited therapeutic options. The subject delves into gene therapy approaches, such as gene editing, gene augmentation, and gene silencing, to correct or modify genetic defects. Cell-based therapies involve the transplantation of engineered cells to restore tissue function, enhance immune responses, or target cancer cells. The conference on Gene Therapy and Cell-Based Therapies brings together leading scientists, clinicians, and researchers to share breakthroughs and discuss challenges in translating these advanced therapies to the clinic. By fostering collaboration and knowledge exchange, this subject aims to accelerate the development and implementation of gene therapy and cell-based treatments, offering new hope for patients with previously incurable diseases.

Session on Clinical Trials and Translational Research

Clinical Trials and Translational Research play a pivotal role in bringing scientific discoveries from the laboratory to real-world applications, advancing medical treatments and improving patient care. This subject delves into the process of translating scientific knowledge into clinical practice through well-designed clinical trials and evidence-based research. The subject explores the various phases of clinical trials, from preclinical studies to post-marketing surveillance, emphasizing the importance of rigorous study designs, patient safety, and ethical considerations. Translational research seeks to bridge the gap between basic research and clinical applications, facilitating the development of novel therapeutics and diagnostic tools. The conference on Clinical Trials and Translational Research brings together experts, researchers, and industry professionals to share best practices, discuss emerging trends, and explore innovative approaches. By fostering collaboration and knowledge exchange, this subject aims to accelerate the translation of scientific discoveries into effective treatments, contributing to advancements in healthcare and medical science.

Session on Digital Health and Artificial Intelligence in Pharma

Digital Health and Artificial Intelligence (AI) in Pharma are transformative subjects that leverage technology to revolutionize the pharmaceutical industry. This interdisciplinary field explores the integration of digital health solutions and AI algorithms to enhance drug discovery, patient care, and healthcare delivery. The subject delves into the application of AI in analyzing vast datasets, such as genomics and electronic health records, to identify potential drug targets, predict patient responses, and optimize clinical trial designs. Digital health technologies, including wearable devices and remote monitoring tools, enable real-time data collection and patient engagement, empowering individuals to actively manage their health. The conference on Digital Health and Artificial Intelligence in Pharma brings together leading scientists, researchers, and industry experts to discuss innovative applications and challenges in implementing these technologies. By fostering collaboration and knowledge exchange, this subject aims to shape the future of pharmaceutical research and patient-centric healthcare, enhancing treatment outcomes and improving the quality of life for patients worldwide.

Session on Natural Products and Herbal Medicines Research

Natural Products and Herbal Medicines Research is a compelling subject that explores the therapeutic potential of natural compounds derived from plants, animals, and microorganisms. This interdisciplinary field investigates the rich biodiversity of nature to identify and study bioactive molecules with medicinal properties. The subject delves into the isolation, characterization, and pharmacological evaluation of natural products and herbal medicines. It explores their traditional uses, safety profiles, and mechanisms of action, contributing to evidence-based herbal medicine practice. The conference on Natural Products and Herbal Medicines Research convenes experts, ethnobotanists, pharmacologists, and healthcare professionals to share cutting-edge research and discuss sustainable approaches to harnessing the power of nature in medicine. By fostering knowledge exchange and interdisciplinary collaborations, this subject aims to advance the field of natural products research, validating the therapeutic potential of traditional remedies and paving the way for the development of safe and effective herbal medicines for improved global healthcare.

Session on Drug Target Identification and Validation

Drug Target Identification and Validation is a critical subject in pharmaceutical research that involves the identification and validation of potential therapeutic targets for drug development. This interdisciplinary field employs a variety of techniques, such as genomics, proteomics, and computational biology, to uncover molecules or pathways implicated in disease. The subject explores the process of validating these targets through in vitro and in vivo experiments, determining their relevance to disease pathogenesis and therapeutic potential. Robust target identification and validation are essential for optimizing drug discovery and reducing the risk of costly failures in later stages of development. The conference on Drug Target Identification and Validation brings together leading researchers, bioinformaticians, and industry professionals to share innovative approaches and successful case studies. By fostering knowledge exchange and interdisciplinary discussions, this subject aims to accelerate drug discovery efforts, paving the way for more effective and targeted treatments to address unmet medical needs.

Session on Vaccines and Vaccine Development

Vaccines and Vaccine Development are critical subjects that have revolutionized public health by preventing and controlling infectious diseases. This interdisciplinary field explores the design, development, and evaluation of vaccines to stimulate the immune system and confer immunity against specific pathogens. The subject delves into various vaccine types, including live attenuated, inactivated, subunit, and mRNA vaccines, and their mechanisms of action. Vaccine development involves rigorous preclinical and clinical testing to ensure safety, efficacy, and immunogenicity. The conference on Vaccines and Vaccine Development brings together leading scientists, immunologists, and vaccine developers to discuss the latest advancements and challenges in this fast-evolving field. By fostering interdisciplinary collaborations and knowledge exchange, this subject aims to accelerate the development and implementation of vaccines, ultimately protecting populations worldwide from infectious diseases and improving global health outcomes.

Session on Emerging Technologies in Pharmaceutical Research

Emerging Technologies in Pharmaceutical Research is a dynamic subject that explores the latest technological advancements shaping the pharmaceutical industry. This interdisciplinary field encompasses cutting-edge tools and approaches that accelerate drug discovery, development, and personalized medicine. The subject delves into various emerging technologies, such as artificial intelligence, machine learning, high-throughput screening, and CRISPR-Cas9 gene editing. These technologies enable more efficient target identification, lead optimization, and drug repurposing. The conference on Emerging Technologies in Pharmaceutical Research brings together leading researchers, bioinformaticians, and industry experts to share groundbreaking discoveries and discuss the potential applications of these technologies. By fostering collaboration and knowledge exchange, this subject aims to drive innovation and propel pharmaceutical research forward, leading to the development of novel therapies and improving patient outcomes. It offers a platform to explore how the integration of emerging technologies can shape the future of medicine and transform healthcare delivery.

MARKET ANALYSIS

Global Pharma Summit 2024: The pharmaceutical research sector encompasses a vast array of activities aimed at discovering, developing, and bringing novel drugs and therapies to the market. This dynamic field engages numerous stakeholders, including pharmaceutical companies, biotechnology firms, academic institutions, contract research organizations (CROs), and regulatory bodies. The sector's primary objective is to address unmet medical needs, advance medical science, and ultimately improve patient outcomes.

Rising Healthcare Expenditure and Demand: The pharmaceutical research market is experiencing robust growth propelled by escalating healthcare expenditures worldwide. As nations focus on enhancing healthcare infrastructure and offering improved treatment options, the demand for innovative pharmaceuticals continues to surge. Additionally, the increasing prevalence of chronic diseases necessitates the development of effective therapeutic solutions.

Biotechnology and Personalized Medicine: Biotechnology has revolutionized pharmaceutical research by enabling the creation of advanced therapies such as biologics, gene therapies, and cell-based treatments. This trend aligns with the era of personalized medicine, where treatments are tailored to individual patient profiles. Genomics, biomarker identification, and precision therapies are driving this transformation, promising more effective and targeted treatments.

Collaborative Research Ecosystem: Collaborative efforts have become a cornerstone of pharmaceutical research. Industry players are increasingly forming partnerships with academic institutions, CROs, and even competitors to pool resources, expertise, and knowledge. These collaborations expedite the drug discovery process, optimize research costs, and promote cross-disciplinary insights.

Outsourcing to CROs: The outsourcing of research and clinical trials to specialized CROs is a prevalent strategy adopted by pharmaceutical companies. CROs offer expertise in various research phases, from preclinical studies to clinical trials and regulatory submissions. This approach allows pharmaceutical firms to focus on core competencies, manage costs, and streamline research operations.

Regulatory Evolution: The pharmaceutical research landscape operates under strict regulatory frameworks to ensure patient safety and treatment efficacy. The evolving regulatory landscape, driven by advancements in science and technology, presents both opportunities and challenges. Regulatory agencies are increasingly embracing innovative trial designs and flexible approval pathways, facilitating faster access to new therapies.

Technological Advancements: The integration of artificial intelligence (AI), machine learning (ML), and data analytics is transforming pharmaceutical research. AI-driven algorithms analyze vast datasets to identify potential drug candidates, predict drug interactions, and optimize clinical trial designs. ML models aid in target identification, molecule design, and patient stratification, enhancing research efficiency.

Emergence of Real-World Evidence (RWE): Real-world evidence, derived from data collected outside of traditional clinical trials, is gaining prominence. RWE offers insights into treatment outcomes, safety profiles, and patient experiences in real-world settings. Incorporating RWE into pharmaceutical research provides a comprehensive understanding of a drug's impact beyond controlled trial environments.

Pandemic Preparedness and Vaccine Development: The COVID-19 pandemic underscored the agility and innovation within the pharmaceutical research sector. The expedited development and distribution of vaccines highlighted the industry's ability to rapidly respond to global health emergencies. This experience catalyzed investments in vaccine research and spurred discussions on enhancing pandemic preparedness.

High Development Costs: Developing a new drug from discovery to market approval is a capital-intensive endeavor. High costs arise from extensive research, clinical trials, regulatory requirements, and post-market surveillance. The risk of failure during any stage of development further contributes to these costs.

Regulatory Compliance: Stringent regulatory requirements ensure patient safety and product quality but can lead to prolonged development timelines and increased costs. Pharmaceutical companies must navigate complex regulatory pathways while adhering to evolving guidelines.

Past Conference Report

Global Pharma Summit-2023

Welcome to Global Pharma Summit 2023

We are very honour to welcome you all to attend the “Global Pharma Summit-2023” which is happening on May 04-05, 2023 in London, UK. The conference emphasizes the theme ‘‘Exploring innovative developments in Pharmaceutical Research” which will give a worldwide Platform to all Scientific Professionals around the world. You can join our conference as an Oral Presenter, Poster Presenter, Delegate/Attendee or Exhibitor.

Global Pharma Summit covers various aspects of Bio-Pharmaceutics, Pharmaceutical Chemistry, Drug Targeting and Design, Pharmacokinetics and Pharmacodynamics in Drugs, Pharmaceutical Formulation, Bio-structural and Medicinal Chemistry, Pharmaceutical Nanotechnology, Novel Drug Delivery Systems, Smart Drug Delivery Systems, Toxic dynamics and Toxicology, Biomaterials in Drug Delivery, Vaccine Drug Delivery Systems, Medical Devices for Drug Delivery, Biologics & Biosimilars, Pharmaceutical Analysis, Pharmaceutical Process Validation, Pharmaceutical Packaging, Clinical Trials and Clinical Research, Pharmacognosy and Natural Products, Regulatory Affairs and Intellectual Property Rights, Industrial and Physical Pharmacy, Clinical and Hospital Pharmacy, Pharmacovigilance and Risk Management, Pharmacy Education and Practice.